NASDAQ:SRTSSensus Healthcare Stock Price, Forecast & News

Sensus Healthcare's stock was trading at $3.25 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, SRTS stock has decreased by 12.3% and is now trading at $2.85. View which stocks have been most impacted by Coronavirus.

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sensus Healthcare in the last year. There are currently 2 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Sensus Healthcare.

Sensus Healthcare is scheduled to release its next quarterly earnings announcement on Thursday, August 13th 2020. View our earnings forecast for Sensus Healthcare.

Sensus Healthcare Inc (NASDAQ:SRTS) posted its quarterly earnings data on Thursday, May, 7th. The company reported ($0.22) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.04) by $0.18. The company had revenue of $1.68 million for the quarter, compared to analyst estimates of $6.20 million. Sensus Healthcare had a negative return on equity of 11.86% and a negative net margin of 13.47%. View Sensus Healthcare's earnings history.

5 brokerages have issued 12-month target prices for Sensus Healthcare's shares. Their forecasts range from $2.40 to $6.00. On average, they expect Sensus Healthcare's stock price to reach $4.21 in the next twelve months. This suggests a possible upside of 47.7% from the stock's current price. View analysts' price targets for Sensus Healthcare.

Media coverage about SRTS stock has trended somewhat positive recently, according to InfoTrie Sentiment. The research firm identifies negative and positive press coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Sensus Healthcare earned a coverage optimism score of 1.3 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the near future. View the latest news about Sensus Healthcare.

Sensus Healthcare saw a increase in short interest in the month of June. As of June 30th, there was short interest totaling 141,000 shares, an increase of 5.8% from the June 15th total of 133,300 shares. Based on an average daily volume of 32,700 shares, the short-interest ratio is currently 4.3 days. Approximately 1.2% of the shares of the company are sold short. View Sensus Healthcare's Current Options Chain.

Some companies that are related to Sensus Healthcare include Accuray (ARAY), T2 Biosystems (TTOO), Apyx Medical (APYX), TELA Bio (TELA), Soliton (SOLY), Restoration Robotics (HAIR), BeyondAirInc . (XAIR), Venus Concept (VERO), PAVmed (PAVM), Spectral Medical (EDTXF), SANUWAVE Health (SNWV), AIT Therapeutics (AITB), Nephros (NEPH), Pro-Dex (PDEX) and Nephros (NEPHD). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Sensus Healthcare investors own include Ring Energy (REI), Ring Energy (REI), Senseonics (SENS), Sangamo Therapeutics (SGMO), Sorrento Therapeutics (SRNE), Zynerba Pharmaceuticals (ZYNE), Aytu Bioscience (AYTU), Crispr Therapeutics (CRSP), Melinta Therapeutics (MLNT) and Nabriva Therapeutics (NBRV).

(SRTS) raised $20 million in an initial public offering (IPO) on Wednesday, March 30th 2016. The company issued 1,800,000 shares at a price of $10.00-$12.00 per share. Joseph Gunnar and Feltl and Company acted as the underwriters for the IPO and Neidiger, Tucker, Bruner was co-manager.

Sensus Healthcare trades on the NASDAQ under the ticker symbol "SRTS."

Shares of SRTS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of SRTS stock can currently be purchased for approximately $2.85.

Sensus Healthcare has a market capitalization of $47.05 million and generates $27.26 million in revenue each year. The company earns $-1,700,000.00 in net income (profit) each year or ($0.10) on an earnings per share basis. Sensus Healthcare employs 48 workers across the globe.

The official website for Sensus Healthcare is www.sensushealthcare.com.

Sensus Healthcare's mailing address is 851 BROKEN SOUND PARKWAY NW SUITE 215, BOCA RATON FL, 33487. The company can be reached via phone at 561-922-5808 or via email at [email protected]